
Serces to enhance the innovation management capacity of SMEs in the macro-region 1 in Romania
- Funding agency:
- Horizon 2020
- Status:
- awarded
- Location:
- Romania

This summary is generated by AI and may contain errors. Please verify key details against the original description and attachments.
Register and select a membership plan to access this feature.
07 January 2026
PROPOSAL NUMBERS
Call EU4H-2026 SANTE-PJ has closed on 06/01/2026.
126 proposals have been submitted.
The breakdown per topic is:
EU4H-2026-SANTE-PJ-06 - 2
Evaluation results are expected to be communicated in May 2026.
27 October 2025
Additional Supporting Documents Available
Following the Call Information Session held on 9 October 2025, additional documents are now available to provide further clarification on the call specifications and submission requirements. These documents include:
Recording of the Call Information Session webinar
Presentation slides
Consolidated FAQ document addressing common questions
These resources can be accessed via the following link: EU4H-2026-SANTE-PJ Info session.
https://hadea.ec.europa.eu/events/info-session-eu4health-action-grants-awp-2025-2025-10-09_en
TOPIC ID: EU4H-2026-SANTE-PJ-06
Type of grant: Call for proposals
General information
Programme:
Call: EU4H SANTE Action Grants 2025 (EU4H-2026-SANTE-PJ)
Type of action: EU4H-PJG EU4H Project Grants
Type of MGA: EU4H Action Grant Budget-Based [EU4H-AG]
Status: Forthcoming
Deadline model: single-stage
Planned Opening Date: 23 September 2025
Deadline dates: 06 January 2026 17:00 (Brussels time)
Topic description
Expected Impact:
In the short term, this action will provide EURIPID members with a better overview of access, P&R measures and decisions across the Member States.
In the longer term, it is expected to support mutual learning between national authorities and help the Member States in taking better pricing and reimbursement decisions, with a view to improve access, availability, and affordability of medicines. This is in line with the recommendations in the Draghi Report on the future of European competitiveness, and with the priority to ensure supply of affordable medicines, as outlined in the mission letter from Commission President von der Leyen to the Commissioner for Health and Animal Welfare.
The proposed “pricing and reimbursement (‘P&R’) tracker” and access dashboard will allow improved monitoring of patients’ access to medicines across the Union, including for cancer treatments. Having this data available prior to the application of the proposed pharmaceutical reform, will serve to measure the baseline and subsequently the impact of the proposed measures that aim to increase access to medicines across the Union, including for cancer treatments.
Objective:
The objectives are to:
a) measure and increase understanding of patient access to medicines in the Union;
b) increase the quality of the database, in terms of timely/correct data delivery;
c) expand the scope of the EURIPID members (to all the Member States) and data;
d) leverage usefulness of the data beyond external reference pricing purposes.
Scope:
The scope of this action is to develop through the EURIPID database:
a) a “pricing and reimbursement (‘P&R’) tracker”, including national information on early access schemes; P&R applications, status, decision; and P&R criteria or conditions (general and product-specific);
b) access dashboards, building on OECD indicators, including on availability (e.g., coverage status, time-to-reimbursement), affordability (e.g., cost of treatment), accessibility (e.g., consumption/uptake);
c) an annual trend analysis report of access to medicines in the Union;
d) solutions that can facilitate data sharing with EURIPID, such as automatization using application programming interface and machine-machine interaction with each Member State;
e) reinforced interoperability of EURIPID with other existing databases (e.g. the European Shortages Medicine Platform, Substance, Product, Organisation and Referential master data, Product Management Service, etc.) and integrating data assets in the European Health Data Space.
described in section 5 of the call document.
Proposal page limits and layout: described in Part B of the Application Form available in the Submission System.
described in section 6 of the call document.
described in section 6 of the call document.
described in section 7 of the call document.
described section 8 of the call document and the Online Manual.
described in section 9 of the call document.
described in section 4 of the call document.
described in section 10 of the call document.
Call document
Application form templates
Standard application form (EU4H) — the application form specific to this call is available in the Submission System
Detailed budget table (EU4H)
Model Grant Agreements (MGA)
EU4H MGA
EU4H Work Programme
EU4H Regulation 2021/522
EU Financial Regulation 2024/2509
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement
Funding & Tenders Portal Online Manual
Funding & Tenders Portal Terms and Conditions
Funding & Tenders Portal Privacy Statement
Start submission
The submission system is planned to be opened on the date stated on the topic header.
Get support
Please read carefully all provisions below before the preparation of your application.
For help related to this call, please contact [email protected]
Funding & Tenders Portal FAQ – Submission of proposals.
IT Helpdesk – Contact the IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.
Online Manual – Step-by-step online guide through the Portal processes from proposal preparation and evaluation to reporting on your ongoing project. Valid for all 2021-2027 programmes.
EuropeAid is an agency responsible for designing European international cooperation and development policy and delivering aid worldwide. Its purpose is to aid in the reduction and eventual abolition of poverty in developing nations by fostering sustainable development, democracy, peace and security. With its partner nations, EuropeAid walks alongside them on their journey to sustainable development, continually adapting its help to their changing requirements. EuropeAid is also concerned with increasing the value and impact of aid money by ensuring that help is provided appropriately.
Under the donor EC - European Commission, DevelopmentAid covers the following entities:
Departments / Directorate Generals
Agencies
EU Bodies
Covers healthcare services, public health systems, and activities aimed at promoting physical and mental well-being.
Focuses on improving the efficient movement, storage, and management of goods and services across supply chains and trade networks.